Aditxt is trading at $0.01, down 7.14%, with no new company-specific announcement or filing identified for September 15, 2026.
- Available coverage highlights older financing and Ignite Proteomics items.
- The decline comes amid cautious broader-market trading ahead of the Federal Reserve meeting, though market weakness is moderate and does not clearly explain this microcap move.
- Activity level and volume were not provided, so conviction remains limited.